WO2008079363A3 - Substituted tetracycline compounds for treatment of inflammatory skin disorders - Google Patents
Substituted tetracycline compounds for treatment of inflammatory skin disorders Download PDFInfo
- Publication number
- WO2008079363A3 WO2008079363A3 PCT/US2007/026220 US2007026220W WO2008079363A3 WO 2008079363 A3 WO2008079363 A3 WO 2008079363A3 US 2007026220 W US2007026220 W US 2007026220W WO 2008079363 A3 WO2008079363 A3 WO 2008079363A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- treatment
- skin disorders
- inflammatory skin
- tetracycline compounds
- substituted tetracycline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/48—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring being part of a condensed ring system of the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
- C07C237/26—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton of a ring being part of a condensed ring system formed by at least four rings, e.g. tetracycline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
- C07C2603/42—Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
- C07C2603/44—Naphthacenes; Hydrogenated naphthacenes
- C07C2603/46—1,4,4a,5,5a,6,11,12a- Octahydronaphthacenes, e.g. tetracyclines
Abstract
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2673486A CA2673486C (en) | 2006-12-21 | 2007-12-21 | Substituted tetracycline compounds for treatment of inflammatory skin disorders |
EP07870927.6A EP2120963B1 (en) | 2006-12-21 | 2007-12-21 | Substituted tetracycline compounds for treatment of inflammatory skin disorders |
PL07870927T PL2120963T3 (en) | 2006-12-21 | 2007-12-21 | Substituted tetracycline compounds for treatment of inflammatory skin disorders |
AU2007338681A AU2007338681B2 (en) | 2006-12-21 | 2007-12-21 | Substituted tetracycline compounds for treatment of inflammatory skin disorders |
ES07870927T ES2701725T3 (en) | 2006-12-21 | 2007-12-21 | Compounds of substituted tetracycline for the treatment of inflammatory skin disorders |
LTEP07870927.6T LT2120963T (en) | 2006-12-21 | 2007-12-21 | Substituted tetracycline compounds for treatment of inflammatory skin disorders |
DK07870927.6T DK2120963T3 (en) | 2006-12-21 | 2007-12-21 | SUBSTITUTED TETRACYCLINE COMPOUNDS FOR TREATMENT OF INFLAMMATORY SKIN DISORDERS |
SI200732084T SI2120963T1 (en) | 2006-12-21 | 2007-12-21 | Substituted tetracycline compounds for treatment of inflammatory skin disorders |
EP18193283.1A EP3488853A1 (en) | 2006-12-21 | 2007-12-21 | Substituted tetracycline compounds for treatment of inflammatory skin disorders |
CY181101329T CY1121135T1 (en) | 2006-12-21 | 2018-12-11 | SUBSTITUTED FOUR-CYCLINES COMPOUNDS FOR THE TREATMENT OF INFLAMMATIVE SKIN DISORDERS |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87643406P | 2006-12-21 | 2006-12-21 | |
US60/876,434 | 2006-12-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008079363A2 WO2008079363A2 (en) | 2008-07-03 |
WO2008079363A3 true WO2008079363A3 (en) | 2008-10-02 |
Family
ID=39432968
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/026220 WO2008079363A2 (en) | 2006-12-21 | 2007-12-21 | Substituted tetracycline compounds for treatment of inflammatory skin disorders |
Country Status (13)
Country | Link |
---|---|
US (2) | US8513223B2 (en) |
EP (2) | EP3488853A1 (en) |
AU (1) | AU2007338681B2 (en) |
CA (2) | CA2892739A1 (en) |
CY (1) | CY1121135T1 (en) |
DK (1) | DK2120963T3 (en) |
ES (1) | ES2701725T3 (en) |
LT (1) | LT2120963T (en) |
PL (1) | PL2120963T3 (en) |
PT (1) | PT2120963T (en) |
SI (1) | SI2120963T1 (en) |
TR (1) | TR201818983T4 (en) |
WO (1) | WO2008079363A2 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6756365B2 (en) * | 1991-11-06 | 2004-06-29 | Trustees Of Tufts College | Reducing tetracycline resistance in living cells |
AU2466099A (en) * | 1998-01-23 | 1999-08-09 | Trustees Of Tufts College | Pharmaceutically active compounds and methods of use thereof |
US20040224927A1 (en) | 2000-06-16 | 2004-11-11 | Trustees Of Tufts College | 7-N-substituted phenyl tetracycline compounds |
US20020132798A1 (en) | 2000-06-16 | 2002-09-19 | Nelson Mark L. | 7-phenyl-substituted tetracycline compounds |
US7094806B2 (en) | 2000-07-07 | 2006-08-22 | Trustees Of Tufts College | 7, 8 and 9-substituted tetracycline compounds |
US8088820B2 (en) * | 2001-04-24 | 2012-01-03 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds for the treatment of malaria |
CN101786991A (en) | 2003-07-09 | 2010-07-28 | 帕拉特克药品公司 | The tetracycline compound that replaces |
CA2585248A1 (en) * | 2004-10-25 | 2006-05-04 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds |
WO2008127722A1 (en) | 2007-04-12 | 2008-10-23 | Paratek Pharmaceuticals, Inc. | Methods for treating spinal muscular atrophy using tetracycline compounds |
RU2010140682A (en) | 2008-03-05 | 2012-04-10 | Пэрэтек Фамэсьютикэлс, Инк. (US) | METHOD FOR TREATING PATIENTS FROM INFECTION, PHARMACEUTICAL COMPOSITION (OPTIONS) AND MEDICINE |
JP2011517697A (en) * | 2008-04-14 | 2011-06-16 | パラテック ファーマシューティカルズ インコーポレイテッド | Substituted tetracycline compounds |
US9255068B2 (en) * | 2011-05-12 | 2016-02-09 | Warner Chilcott Company, Llc | Crystalline salts of (4S,4AS,5AR,12AS)-4-dimethylamino-3,10,12,12A-tetrahydroxy-7-[methoxy(methyl)amino)-methyl] acid amide and methods of using the same |
US9119793B1 (en) | 2011-06-28 | 2015-09-01 | Medicis Pharmaceutical Corporation | Gastroretentive dosage forms for doxycycline |
JP2015517524A (en) * | 2012-05-14 | 2015-06-22 | パラテック ファーマシューティカルズ インコーポレイテッド | (4S, 4aS, 5aR, 12aS) -4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy (methyl) amino) -methyl] -1,11-dioxo-1,4 Method of using 4a, 5,5a, 6,11,12a-octahydro-naphthacene-2-carboxylic acid amide |
US10842802B2 (en) | 2013-03-15 | 2020-11-24 | Medicis Pharmaceutical Corporation | Controlled release pharmaceutical dosage forms |
JP6793715B2 (en) | 2015-03-23 | 2020-12-02 | バイオファーミクス・インコーポレイテッドBioPharmX, Inc. | Tetracycline skin pharmaceutical composition |
CA3042514A1 (en) | 2016-11-01 | 2018-05-11 | Paratek Pharmaceuticals, Inc. | 9-aminomethyl minocycline compounds and use thereof in treating community-acquired bacterial pneumonia (cabp) |
AU2018303807B2 (en) * | 2017-07-21 | 2023-08-24 | Almirall, Llc | Treatment of non-inflammatory lesions |
CN110156624B (en) * | 2019-05-29 | 2022-03-08 | 河北冀衡药业股份有限公司 | Method for synthesizing minocycline and derivatives thereof |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002004406A2 (en) * | 2000-07-07 | 2002-01-17 | Trustees Of Tufts College | 9-substituted minocycline compounds |
WO2002004407A2 (en) * | 2000-07-07 | 2002-01-17 | Trustees Of Tufts College | 7-substituted tetracycline compounds |
WO2002072532A1 (en) * | 2001-03-13 | 2002-09-19 | Paratek Pharmaceuticals, Inc. | 7, 9-substituted tetracycline compounds |
WO2002072506A2 (en) * | 2001-03-13 | 2002-09-19 | Paratek Pharmaceuticals, Inc. | 7-pyrollyl tetracycline compounds and methods of use thereof |
WO2002072022A2 (en) * | 2001-03-14 | 2002-09-19 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds as antifungal agents |
WO2003005971A2 (en) * | 2001-07-13 | 2003-01-23 | Paratek Pharmaceuticals, Inc. | Tetracycline compounds having target therapeutic activities |
WO2003057169A2 (en) * | 2002-01-08 | 2003-07-17 | Paratek Pharmaceuticals, Inc. | 4-dedimethylamino tetracycline compounds |
WO2003075857A2 (en) * | 2002-03-08 | 2003-09-18 | Paratek Pharmaceuticals, Inc. | Amino-methyl substituted tetracycline compounds |
WO2003079984A2 (en) * | 2002-03-21 | 2003-10-02 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds |
WO2003088906A2 (en) * | 2002-04-16 | 2003-10-30 | Collagenex Pharmaceuticals, Inc. | Methods of simultaneously treating ocular rosacea and acne rosacea |
WO2004064728A2 (en) * | 2003-01-16 | 2004-08-05 | Paratek Pharmaceuticals, Inc. | Use of specific tetracycline compounds in therapy |
WO2004091513A2 (en) * | 2003-04-10 | 2004-10-28 | Paratek Pharmaceuticals, Inc. | 9-aminomethyl substituted minocycline compounds |
WO2005009943A2 (en) * | 2003-07-09 | 2005-02-03 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds |
WO2006047756A2 (en) * | 2004-10-25 | 2006-05-04 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds |
Family Cites Families (87)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2990331A (en) | 1956-11-23 | 1961-06-27 | Pfizer & Co C | Stable solutions of salts of tetracyclines for parenteral administration |
US2980584A (en) | 1957-10-29 | 1961-04-18 | Pfizer & Co C | Parenteral magnesium oxytetracycline acetic or lactic acid carboxamide vehicle preparation |
US3062717A (en) | 1958-12-11 | 1962-11-06 | Pfizer & Co C | Intramuscular calcium tetracycline acetic or lactic acid carboxamide vehicle preparation |
FR1003M (en) | 1960-03-09 | 1961-12-18 | Erba Carlo Spa | Tetracycline-based antibiotic derivatives. |
US3165531A (en) | 1962-03-08 | 1965-01-12 | Pfizer & Co C | 13-substituted-6-deoxytetracyclines and process utilizing the same |
GB1108310A (en) | 1964-04-30 | 1968-04-03 | Pfizer & Co C | Derivatives of 6-methylene-tetracycline and process for their preparation |
US3454697A (en) | 1965-06-08 | 1969-07-08 | American Cyanamid Co | Tetracycline antibiotic compositions for oral use |
US3304227A (en) * | 1965-07-15 | 1967-02-14 | Loyal E Loveless | Antibiotic-containing animal feed |
NL6607516A (en) | 1966-05-31 | 1967-12-01 | ||
DE1767891C3 (en) | 1968-06-28 | 1980-10-30 | Pfizer | Process for the preparation of aqueous medicinal solutions for parenteral, peroral and local use containing a tetracycline derivative |
NL158172B (en) | 1972-09-18 | 1978-10-16 | Farmaceutici Italia | PROCESS FOR PREPARING TETRACYCLINE DERIVATIVES WITH A 7-PLACE SUBSTITUENT. |
US3957980A (en) | 1972-10-26 | 1976-05-18 | Pfizer Inc. | Doxycycline parenteral compositions |
JPS5119757A (en) | 1974-06-25 | 1976-02-17 | Farmaceutici Italia | ARUKIRUTETORASAIKURIN JUDOTAINOSEIZOHO |
DE2442829A1 (en) | 1974-09-06 | 1976-03-18 | Merck Patent Gmbh | TETRACYCLIC COMPOUNDS AND PROCEDURES FOR THEIR PRODUCTION |
US4018889A (en) | 1976-01-02 | 1977-04-19 | Pfizer Inc. | Oxytetracycline compositions |
US4126680A (en) | 1977-04-27 | 1978-11-21 | Pfizer Inc. | Tetracycline antibiotic compositions |
US5589470A (en) | 1990-02-26 | 1996-12-31 | Trustees Of Tufts College | Reducing tetracycline resistance in living cells |
US5064821A (en) | 1982-11-18 | 1991-11-12 | Trustees Of Tufts College | Method and compositions for overcoming tetracycline resistance within living cells |
US4806529A (en) | 1982-11-18 | 1989-02-21 | Trustees Of Tufts College, Tufts University | Tetracycline activity enhancement |
US4704383A (en) * | 1983-12-29 | 1987-11-03 | The Research Foundation Of State University Of New York | Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same |
US4935412A (en) * | 1983-12-29 | 1990-06-19 | The Research Foundation Of State University Of New York | Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same |
US4925833A (en) * | 1983-12-29 | 1990-05-15 | The Research Foundation Of State University Of New York | Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis |
US4666897A (en) * | 1983-12-29 | 1987-05-19 | Research Foundation Of State University | Inhibition of mammalian collagenolytic enzymes by tetracyclines |
USRE34656E (en) * | 1983-12-29 | 1994-07-05 | The Research Foundation Of State University Of New York | Use of tetracycline to enhance bone protein synthesis and/or treatment of bone deficiency |
US4806372A (en) | 1985-02-15 | 1989-02-21 | Georgia Oil & Gas Co., Inc. | Nitrite-free-curing of bacon and product thereof |
US5308839A (en) * | 1989-12-04 | 1994-05-03 | The Research Foundation Of State University Of New York | Composition comprising non-steroidal anti-inflammatory agent tenidap and effectively non-antibacterial tetracycline |
JP3016587B2 (en) * | 1989-12-04 | 2000-03-06 | ザ・リサーチ・ファンデーション・オブ・ステート・ユニバーシティ・オブ・ニューヨーク | Combination of non-steroidal anti-inflammatory drug and tetracycline |
US5770588A (en) * | 1991-02-11 | 1998-06-23 | The Research Foundation Of State University Of New York | Non-antibacterial tetracycline compositions of the prevention and treatment of root caries |
US5231017A (en) * | 1991-05-17 | 1993-07-27 | Solvay Enzymes, Inc. | Process for producing ethanol |
US6756365B2 (en) | 1991-11-06 | 2004-06-29 | Trustees Of Tufts College | Reducing tetracycline resistance in living cells |
US5258371A (en) * | 1992-05-29 | 1993-11-02 | Kuraray Co., Ltd. | Method to reduce connective tissue destruction |
US6043225A (en) * | 1992-06-12 | 2000-03-28 | Board Of Regents Of The University Of Washington | Diagnosis and treatment of arterial chlamydial granuloma |
DK0599397T3 (en) * | 1992-11-17 | 1996-09-16 | Univ New York State Res Found | Tetracyclines, including non-microbial, chemically modified tetracyclines, inhibit excessive collagen cross-linking in diabetes |
US5523297A (en) * | 1993-03-02 | 1996-06-04 | The Research Foundation Of State University Of New York | Inhibition of excessive phospholipase A2 activity and/or production by non-antimicrobial tetracyclines |
US6043231A (en) * | 1993-03-02 | 2000-03-28 | The Research Foundation Of State Univ. Of New York | Inhibition of excessive phospholipase A2 activity and/or production by non-antimicrobial tetracyclines |
US5668122A (en) * | 1993-07-28 | 1997-09-16 | Fife; Rose S. | Method to treat cancer with tetracyclines |
AU1279095A (en) | 1994-02-17 | 1995-09-04 | Pfizer Inc. | 9-(substituted amino)-alpha-6-deoxy-5-oxy tetracycline derivatives, their preparation and their use as antibiotics |
US5843925A (en) * | 1994-12-13 | 1998-12-01 | American Cyanamid Company | Methods for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growth |
AU693013B2 (en) | 1995-05-03 | 1998-06-18 | Pfizer Inc. | Novel tetracycline derivatives |
US5834449A (en) * | 1996-06-13 | 1998-11-10 | The Research Foundation Of State University Of New York | Treatment of aortic and vascular aneurysms with tetracycline compounds |
US5827840A (en) * | 1996-08-01 | 1998-10-27 | The Research Foundation Of State University Of New York | Promotion of wound healing by chemically-modified tetracyclines |
US5789395A (en) * | 1996-08-30 | 1998-08-04 | The Research Foundation Of State University Of New York | Method of using tetracycline compounds for inhibition of endogenous nitric oxide production |
US5919774A (en) * | 1996-12-10 | 1999-07-06 | Eli Lilly And Company | Pyrroles as sPLA2 inhibitors |
US5837696A (en) * | 1997-01-15 | 1998-11-17 | The Research Foundation Of State University Of New York | Method of inhibiting cancer growth |
US5773430A (en) * | 1997-03-13 | 1998-06-30 | Research Foundation Of State University Of New York | Serine proteinase inhibitory activity by hydrophobic tetracycline |
US5929055A (en) * | 1997-06-23 | 1999-07-27 | The Research Foundation Of State University Of New York | Therapeutic method for management of diabetes mellitus |
AU2466099A (en) | 1998-01-23 | 1999-08-09 | Trustees Of Tufts College | Pharmaceutically active compounds and methods of use thereof |
US6277061B1 (en) * | 1998-03-31 | 2001-08-21 | The Research Foundation Of State University Of New York | Method of inhibiting membrane-type matrix metalloproteinase |
US6015804A (en) * | 1998-09-11 | 2000-01-18 | The Research Foundation Of State University Of New York | Method of using tetracycline compounds to enhance interleukin-10 production |
US5977091A (en) * | 1998-09-21 | 1999-11-02 | The Research Foundation Of State University Of New York | Method of preventing acute lung injury |
US5998390A (en) * | 1998-09-28 | 1999-12-07 | The Research Foundation Of State University Of New York | Combination of bisphosphonate and tetracycline |
US6256365B1 (en) | 1999-08-16 | 2001-07-03 | Analogic Corporation | Apparatus and method for reconstruction of images in a computed tomography system using oblique slices |
US6849615B2 (en) | 1999-09-14 | 2005-02-01 | Paratek Pharmaceuticals, Inc. | 13-substituted methacycline compounds |
US6500812B2 (en) | 1999-09-14 | 2002-12-31 | Paratek Pharmaceuticals, Inc. | 13-substituted methacycline compounds |
CN102336680A (en) | 1999-09-14 | 2012-02-01 | 塔夫茨大学信托人 | Methods of preparing substituted tetracyclines with transition metal-based chemistries. |
US6231894B1 (en) * | 1999-10-21 | 2001-05-15 | Duke University | Treatments based on discovery that nitric oxide synthase is a paraquat diaphorase |
EP1263442A1 (en) | 2000-01-24 | 2002-12-11 | Trustees Of Tufts College | TETRACYCLINE COMPOUNDS FOR TREATMENT OF i CRYPTOSPORIDIUM PARVUM /i RELATED DISORDERS |
US6818634B2 (en) | 2000-03-31 | 2004-11-16 | Paratek Pharmaceuticals, Inc. | 7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds |
CA2409063A1 (en) | 2000-05-15 | 2001-11-22 | Mark L. Nelson | 7-substituted fused ring tetracycline compounds |
US20020132798A1 (en) | 2000-06-16 | 2002-09-19 | Nelson Mark L. | 7-phenyl-substituted tetracycline compounds |
US20020128238A1 (en) | 2000-06-16 | 2002-09-12 | Nelson Mark L. | 7-phenyl-substituted tetracycline compounds |
US20040224927A1 (en) | 2000-06-16 | 2004-11-11 | Trustees Of Tufts College | 7-N-substituted phenyl tetracycline compounds |
CA2415086A1 (en) | 2000-07-07 | 2002-01-17 | Trustees Of Tufts College | 7,8 and 9-substituted tetracycline compounds |
US7094806B2 (en) | 2000-07-07 | 2006-08-22 | Trustees Of Tufts College | 7, 8 and 9-substituted tetracycline compounds |
US20050143353A1 (en) | 2000-07-07 | 2005-06-30 | Paratek Pharmaceuticals, Inc. | 13-Substituted methacycline compounds |
EP1241160A1 (en) | 2001-03-13 | 2002-09-18 | Glaxo Group Limited | Tetracycline derivatives and their use as antibiotic agents |
US7553828B2 (en) | 2001-03-13 | 2009-06-30 | Paratek Pharmaceuticals, Inc. | 9-aminomethyl substituted minocycline compounds |
CA2440757A1 (en) | 2001-03-14 | 2002-09-19 | Michael Draper | Substituted tetracycline compounds as synergistic antifungal agents |
US8088820B2 (en) | 2001-04-24 | 2012-01-03 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds for the treatment of malaria |
US20060194773A1 (en) | 2001-07-13 | 2006-08-31 | Paratek Pharmaceuticals, Inc. | Tetracyline compounds having target therapeutic activities |
WO2003055441A2 (en) | 2001-08-02 | 2003-07-10 | Paratek Pharmaceuticals, Inc. | Medicaments |
WO2003023568A2 (en) | 2001-09-10 | 2003-03-20 | Paratek Pharmaceuticals, Inc. | Computational method for determining oral bioavailability |
EP1534300A4 (en) | 2002-07-12 | 2008-04-23 | Paratek Pharm Innc | 3, 10, and 12a substituted tetracycline compounds |
WO2004038000A2 (en) | 2002-10-24 | 2004-05-06 | Paratek Pharmaceuticals, Inc. | Methods of using substituted tetracycline compounds to modulate rna |
US20060287283A1 (en) | 2003-07-09 | 2006-12-21 | Paratek Pharmaceuticals, Inc. | Prodrugs of 9-aminomethyl tetracycline compounds |
EP2332904A3 (en) | 2004-01-15 | 2012-04-11 | Paratek Pharmaceuticals, Inc. | Derivatives of tetracycline compounds |
WO2005082860A1 (en) | 2004-02-27 | 2005-09-09 | National Research Council Of Canada | Tetracyclines and their use as calpain inhibitors |
AU2005299294B2 (en) | 2004-10-25 | 2012-06-07 | Paratek Pharmaceuticals, Inc. | 4-aminotetracyclines and methods of use thereof |
WO2006084265A1 (en) | 2005-02-04 | 2006-08-10 | Paratek Pharmaceuticals, Inc. | 11a, 12-DERIVATIVES OF TETRACYCLINE COMPOUNDS |
JP2009502809A (en) * | 2005-07-21 | 2009-01-29 | パラテック ファーマシューティカルズ インコーポレイテッド | 10-Substituted Tetracycline and Method of Use |
AU2007208214B2 (en) | 2006-01-24 | 2013-02-14 | Paratek Pharmaceuticals, Inc. | Methods of increasing oral bioavailability of tetracyclines |
JP2009543544A (en) | 2006-05-15 | 2009-12-10 | パラテック ファーマシューティカルズ インコーポレイテッド | Methods for modulating gene or gene product expression using substituted tetracycline compounds |
WO2008045507A2 (en) | 2006-10-11 | 2008-04-17 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds for treatment of bacillus anthracis infections |
WO2008079339A2 (en) * | 2006-12-21 | 2008-07-03 | Paratek Pharmaceuticals, Inc. | Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections |
WO2008127722A1 (en) | 2007-04-12 | 2008-10-23 | Paratek Pharmaceuticals, Inc. | Methods for treating spinal muscular atrophy using tetracycline compounds |
US9434680B2 (en) | 2007-04-27 | 2016-09-06 | Paratek Pharmaceuticals, Inc. | Methods for synthesizing and purifying aminoalkyl tetracycline compounds |
DK2176216T3 (en) | 2007-07-06 | 2012-07-30 | Paratek Pharm Innc | Methods for synthesizing 9-substituted minocycline |
-
2007
- 2007-12-21 EP EP18193283.1A patent/EP3488853A1/en active Pending
- 2007-12-21 CA CA2892739A patent/CA2892739A1/en not_active Abandoned
- 2007-12-21 LT LTEP07870927.6T patent/LT2120963T/en unknown
- 2007-12-21 US US11/963,509 patent/US8513223B2/en active Active
- 2007-12-21 PL PL07870927T patent/PL2120963T3/en unknown
- 2007-12-21 DK DK07870927.6T patent/DK2120963T3/en active
- 2007-12-21 CA CA2673486A patent/CA2673486C/en active Active
- 2007-12-21 TR TR2018/18983T patent/TR201818983T4/en unknown
- 2007-12-21 PT PT07870927T patent/PT2120963T/en unknown
- 2007-12-21 EP EP07870927.6A patent/EP2120963B1/en active Active
- 2007-12-21 SI SI200732084T patent/SI2120963T1/en unknown
- 2007-12-21 AU AU2007338681A patent/AU2007338681B2/en active Active
- 2007-12-21 WO PCT/US2007/026220 patent/WO2008079363A2/en active Application Filing
- 2007-12-21 ES ES07870927T patent/ES2701725T3/en active Active
-
2013
- 2013-08-19 US US13/987,655 patent/US9481639B2/en active Active
-
2018
- 2018-12-11 CY CY181101329T patent/CY1121135T1/en unknown
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002004406A2 (en) * | 2000-07-07 | 2002-01-17 | Trustees Of Tufts College | 9-substituted minocycline compounds |
WO2002004407A2 (en) * | 2000-07-07 | 2002-01-17 | Trustees Of Tufts College | 7-substituted tetracycline compounds |
WO2002072532A1 (en) * | 2001-03-13 | 2002-09-19 | Paratek Pharmaceuticals, Inc. | 7, 9-substituted tetracycline compounds |
WO2002072506A2 (en) * | 2001-03-13 | 2002-09-19 | Paratek Pharmaceuticals, Inc. | 7-pyrollyl tetracycline compounds and methods of use thereof |
WO2002072022A2 (en) * | 2001-03-14 | 2002-09-19 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds as antifungal agents |
WO2003005971A2 (en) * | 2001-07-13 | 2003-01-23 | Paratek Pharmaceuticals, Inc. | Tetracycline compounds having target therapeutic activities |
WO2003057169A2 (en) * | 2002-01-08 | 2003-07-17 | Paratek Pharmaceuticals, Inc. | 4-dedimethylamino tetracycline compounds |
WO2003075857A2 (en) * | 2002-03-08 | 2003-09-18 | Paratek Pharmaceuticals, Inc. | Amino-methyl substituted tetracycline compounds |
WO2003079984A2 (en) * | 2002-03-21 | 2003-10-02 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds |
WO2003088906A2 (en) * | 2002-04-16 | 2003-10-30 | Collagenex Pharmaceuticals, Inc. | Methods of simultaneously treating ocular rosacea and acne rosacea |
WO2004064728A2 (en) * | 2003-01-16 | 2004-08-05 | Paratek Pharmaceuticals, Inc. | Use of specific tetracycline compounds in therapy |
WO2004091513A2 (en) * | 2003-04-10 | 2004-10-28 | Paratek Pharmaceuticals, Inc. | 9-aminomethyl substituted minocycline compounds |
WO2005009943A2 (en) * | 2003-07-09 | 2005-02-03 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds |
WO2006047756A2 (en) * | 2004-10-25 | 2006-05-04 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds |
Non-Patent Citations (1)
Title |
---|
XIE JIAN ET AL: "Squaric acids: A new motif for designing inhibitors of protein tyrosine phosphatases.", ORGANIC LETTERS, vol. 6, no. 1, 8 January 2004 (2004-01-08), pages 83 - 86, XP002483692, ISSN: 1523-7060 * |
Also Published As
Publication number | Publication date |
---|---|
AU2007338681B2 (en) | 2013-09-26 |
US9481639B2 (en) | 2016-11-01 |
TR201818983T4 (en) | 2019-01-21 |
LT2120963T (en) | 2019-01-10 |
DK2120963T3 (en) | 2019-01-14 |
US8513223B2 (en) | 2013-08-20 |
EP2120963B1 (en) | 2018-09-12 |
EP3488853A1 (en) | 2019-05-29 |
EP2120963A2 (en) | 2009-11-25 |
WO2008079363A2 (en) | 2008-07-03 |
US20130345179A1 (en) | 2013-12-26 |
PL2120963T3 (en) | 2019-05-31 |
ES2701725T3 (en) | 2019-02-25 |
CA2892739A1 (en) | 2008-07-03 |
SI2120963T1 (en) | 2019-02-28 |
US20080312193A1 (en) | 2008-12-18 |
CA2673486C (en) | 2015-09-08 |
AU2007338681A1 (en) | 2008-07-03 |
PT2120963T (en) | 2018-12-17 |
CY1121135T1 (en) | 2019-12-11 |
CA2673486A1 (en) | 2008-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008079363A3 (en) | Substituted tetracycline compounds for treatment of inflammatory skin disorders | |
WO2007100617A3 (en) | Imidazole-based compounds, compositions comprising them and methods of their use | |
EP1987141B8 (en) | Compositions suitable for treating collagen-mediated diseases | |
IL233634A0 (en) | Methods, compositions, and kits for the treatment of medical conditions | |
WO2008120098A3 (en) | Peptide prodrugs | |
WO2008097561A8 (en) | Oxabicycloheptanes and oxabicycloheptenes, their preparation and use | |
MX2009006536A (en) | Organic compounds and their uses. | |
WO2008124660A3 (en) | Methods and compositions for the treatment of cancer | |
EP1868628A4 (en) | Compounds, compositions and methods for the treatment of poxvirus infections | |
WO2008100805A3 (en) | Anti-robo4 antibodies and uses therefor | |
WO2007095638A3 (en) | Boron-containing small molecules as anti-inflammatory agents | |
WO2006119295A3 (en) | Compositions and methods for the treatment of neurodegenerative diseases | |
WO2008034013A3 (en) | Medical devices and methods of making the same | |
WO2008106226A3 (en) | Macrolide compounds and methods of making and using the same | |
WO2008060767A3 (en) | Macrocyclic benzofused pyrimidine derivatives | |
WO2009042114A3 (en) | Phenazine derivatives and uses thereof | |
WO2008054676A3 (en) | Medical devices and methods of using the same | |
WO2009036175A3 (en) | F1f0-atpase inhibitors and related methods | |
WO2009129246A3 (en) | Compositions and methods for preparing and using same | |
WO2010048273A3 (en) | Methods and compounds for treatment of neurodegenerative disorders | |
TNSN08400A1 (en) | Organic compounds and their uses | |
WO2008013589A3 (en) | Treatment of ras-expressing tumors | |
WO2008027600A3 (en) | Imatinib compositions | |
WO2009002423A3 (en) | Polycyclic guanine derivatives and use thereof | |
WO2008045507A3 (en) | Substituted tetracycline compounds for treatment of bacillus anthracis infections |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07870927 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2673486 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007338681 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007870927 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2007338681 Country of ref document: AU Date of ref document: 20071221 Kind code of ref document: A |